Venlafaxine inhibits naloxone-precipitated morphine withdrawal symptoms: Role of inflammatory cytokines and nitric oxide

Metabolic Brain Disease - Opioid-induced neuroinflammation plays a role in the development of opioid physical dependence. Moreover, nitric oxide (NO) has been implicated in several oxidative and...     

Nutritional inadequacy in adults with muscular dystrophy

Patients with muscular dystrophy may be prone to nutrient deficiency due to mobility limitations or oropharyngeal weakness. Patients with myotonic muscular dystrophy (DM1) may be particularly prone to nutritional deficiencies from associated dysmotility of the entire gastrointestinal tract. We prospectively evaluated nutritional intake, body composition, and muscle strength in adult patients with DM1 (n = 29) and other muscular dystrophies (n = 22) on two occasions separated by approximately 6 months. Handgrip was significantly lower and knee extension higher for DM1 compared to other dystrophies, with no between-group differences in nutritional intakes. Many patients in both groups demonstrated inadequate nutrient intake of protein, energy, vitamins (water and fat soluble), and minerals (calcium and magnesium). Significant correlations were found between measures of strength and certain individual nutrients (e.g., copper and water-soluble vitamins). These data indicate that a substantial number of adults with muscular dystrophy do not meet current dietary intake recommendations. The potential clinical implications of these findings are discussed.     

High levels of CA125 (over 1,000 IU/ml) in patients with gynecologic disease and no malignant conditions: three cases and literature review

Objective To report the very high serum levels of CA125 in patients with benign gynecologic disease which manifests as pelvic mass. Methods Clinical data of three cases with high levels of CA125 over 1,000 IU/ml and benign gynecologic conditions were gathered. in Vali-Asr hospital. Results Three patients were scheduled for laparatomy as ovarian cancer and leiomyosarcoma. Histologic results after laparatomy showed uterine myoma in two patients and endometrioma in a third patient. Conclusion High levels of CA125 over 1,000 IU/ml, may be showed in other gynecologic conditions with no malignancy. So, other clinical and imaging data could be helpful for differential diagnosis of these patients.     

Warfarin-induced leukocytoclastic vasculitis

Skin reactions associated with oral coumarin-derived anticoagulants are an uncommon occurrence. Leukocytoclastic vasculitis (LV) is primarily a cutaneous small vessel vasculitis, though systemic involvement may be encountered. We report 4 patients with late-onset LV probably due to warfarin. All 4 patients presented with skin eruptions that developed after receiving warfarin for several years. The results of skin lesion biopsies were available in 3 patients, confirming LV Cutaneous lesions resolved in all patients after warfarin was discontinued. In 2 of the 4 patients, rechallenge with warfarin led to recurrence of the lesions. LV may be a late-onset adverse reaction associated with warfarin therapy.     

Applications of Cu(0) encapsulated nanocatalysts as superior catalytic systems in Cu-catalyzed organic transformations

Recently, Cu nanoparticles (NPs) encapsulated into various materials as supports (e.g., zeolite, silica) have attracted much devotion due to their unique catalytic properties such as high catalytic activity, intensive reactivity and selectivity through highly protective properties. Nowadays, the superior catalytic activity of Cu-NPs, encapsulated onto zeolite, silica and different porous systems, is extensively investigated and now well-established. As a matter of fact, Cu-NPs are protected from deactivation by this kind of encapsulation. Thus, their exclusion proceeds smoothly, and their recyclability is significantly increased. Cu-NPs have been used as potential heterogeneous catalysts in different chemical transformations. In this review, we try to show the preparation and applications of Cu(0) encapsulated nanocatalysts in zeolite and silica as superior catalytic systems in Cu-catalyzed organic transformations. In addition, the catalytic activity of these encapsulated Cu-NPs in different important organic transformations (such as hydrogenation, oxidation and carbon–carbon bond formations) are compared with those of a variety of organic, inorganic and hybrid porous bearing a traded metal ion. Moreover, the results from the TGA/DTA analysis and optical properties of Cu-complexes are demonstrated. The inherited characteristic merits of the encapsulated Cu-NPs onto zeolite and silica, such as their low leaching, catalytic activity, reusability economic feasibility and originality are critically considered.

In this review, the catalytic activity of encapsulated Cu-NPs in different important organic transformations is compared with those of a variety of organic, inorganic and hybrid porous materials bearing a traded metal ion.